Traditional Chinese medicine ningdong granule: The beneficial effects in tourette's disorder

Journal of International Medical Research

Volumn 38, Issue 1, 2010, Pages 169-175

  Zhao, L ^a   Li, An Yuan ^a   Lv, H ^a   Liu, F Y ^a   Qi, F H ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Clinical trial; Herbal; Neurology; Ningdong granule; Paediatrics; Tourette's disorder; Traditional Chinese medicine

Indexed keywords

CHINESE DRUG; CODONOPSIS PILOSULA EXTRACT; GASTRODIA ELATA EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; NINGDONG GRANULE; OPHIOPOGON ROOT; PAEONIA LACTIFLORA EXTRACT; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BODY MASS; BOVIDS; CHILD; CHINESE MEDICINE; CLINICAL TRIAL; CODONOPSIS PILOSULA; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EARTHWORM; ELECTROCARDIOGRAM; ELEPHANT; FEMALE; GASTRODIA ELATA; GILLES DE LA TOURETTE SYNDROME; HORSE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OYSTER; PHERETIMA ASPERGILLUM; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIC; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77749277506     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800119     Document Type: Article

References (27)

1. Singer HS: Tourette's syndrome: from behaviour to biology. Lancet Neurol 2005; 4: 149 - 159.
2. Robertson MM: The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008; 65: 461- 472.
3. Leckman JF: Tourette's syndrome. Lancet 2002; 360: 1577-1586.
4. Erenberg G, Cruse RP, Rothner AD: The natural history of Tourette syndrome: a follow-up study. Ann Neurol 1987; 22: 383-385.
5. Brunn RD: Subtle and under-recognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 1988; 145: 621-624.
6. Riddle MA, Hardin MT, Towbin KE, et al: Tardive dyskinesia following haloperidol treatment in Tourette's syndrome. Arch Gen Psychiatry 1987; 44: 98-99.
7. Richardson MA, Haugland G, Craig TJ: Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatry 1991; 148: 1322-1328.
8. Sallee FR, Nesbitt L, Jackson C, et al: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997; 154: 1057-1062.
9. Bruggeman R, van der Linden C, Buitelaar JK, et al: Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001; 62: 50-56.
10. Dion Y, Annable L, Sandor P, et al: Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002; 22: 31-39.
11. Budman CL, Gayer A, Lesser M, et al: An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 2001; 62: 290-294.
12. Margolese HC, Annable L, Dion Y: Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone. J Clin Psychiatry 2002; 63: 1040-1044.
13. Awaad Y, Michon AM, Minarik S: Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005; 20: 714-718.
14. Smith-Hicks CL, Bridges DD, Paynter NP, et al: A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007; 22: 1764-1770.
15. Anastasi JK, Currie LM, Kim GH: Understanding diagnostic reasoning in TCM practice: tongue diagnosis. Altern Ther Health Med 2009; 15: 18-28.
16. Li AY, Ma RP, Lv H, et al: Clinical study of Ningdong granule in treating Tourette syndrome. J Shandong Univ TCM 2008; 32: 33-35 [in Chinese].
17. Lv H, Li A, Ma H, et al: Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. J Ethnopharmacol 2009; 124: 488-492.
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 2000.
19. Performance of children with epilepsy and normal age-matched controls on the WISC-III. Child Neuropsychol 2006; 12: 173-180.
20. Zhong yq, Wu J, Xie Xl, et al: The introduction of Yale Global Tic Severity Scale into the clinical evaluation of children with tic disorders. Chin J Pract Pediatr 2006; 21: 214-216 [in Chinese].
21. Feng NP (ed): Principle and Application of TCM Extract and Separation Technology. Beijing: China Medical Science and Technology Press, 2005; pp 38-42 [in Chinese].
22. National Pharmacopoeia Committee: Pharmacopoeia of China. Beijing: Chinese Publishing Company of the Chemical Industry, 2005; pp 22, 39, 59, 68, 80, 106, 120, 199 [in Chinese].
23. Li JJ: An-yuan Li's experience of treatment for Tourette's disorder. J Trad Chin Med 2009; 50: 15-16 [in Chinese].
24. Leckman JF, Riddle MA, Hardin MT, et al: The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28: 566-573.
25. Scahill L, Riddle MA, McSwiggin-Hardin M, et al: Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 844-852.
26. March JS, Parker JD, Sullivan K, et al: The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 554-565.
27. Kovacs M: The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985; 21: 995-998.